Penserra Capital Management LLC Surface Oncology, Inc. Transaction History

Penserra Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$4.73 - $7.9 $4,919 - $8,216	-1,040 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$5.16 - $7.98 $258 - $399	50 Added 5.05%	1,040 $7,000
Q2 2021 Aug 12, 2021	BUY	$6.45 - $9.09 $387 - $545	60 Added 6.45%	990 $7,000
Q1 2021 May 13, 2021	SELL	$7.25 - $13.82 $253 - $483	-35 Reduced 3.63%	930 $7,000
Q4 2020 Feb 12, 2021	BUY	$6.87 - $10.48 $6,629 - $10,113	965 New	965 $8,000

315K

Ticker SURF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,034,000
Description
Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibo...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.